Phase II Investigation definition

Phase II Investigation has the meaning ascribed to such term in Section 5.17(b).
Sample 1Sample 2
Phase II Investigation an in-depth investigation of the effects of the Offer on the relevant markets, following completion of an initial review, as applicable under the laws of the respective jurisdiction; "Registrar of Companies" the Registrar of Companies in England and Wales; "Regulatory Information Service" a "primary information provider" which has been approved by the FCA as such to disseminate regulated information; "Resolution(s)" such shareholder resolution(s) of Xpediator as are necessary to approve, implement and effect the Scheme, including (without limitation) a resolution to make certain amendments to the articles of association of Xpediator;
Sample 1
Phase II Investigation means the in-depth investigation by the European Commission pursuant to Article 6(1)(c) of the EU Merger Regulation, or, in case the European Commission makes a referral in whole or in part under article 4 or 9 of the EU Merger Regulation, an in-depth investigation by the Dutch Competition Authority pursuant to Article 37(2) of the Dutch Competition Act and, if applicable, a similar in-depth investigation by other Regulatory Authorities of Member State(s) to which the transaction may be referred. Position Statement means the position statement of the Boards to be issued in connection with the Offer.
Sample 1

Examples of Phase II Investigation in a sentence

  • XxXxxx Title: Vice President Schedule I Pre-Closing Known Remedial Liabilities Hazardous contamination identified in the report entitled Phase II Investigation dated August 1998 for the Colstrip Project prepared for Montana Power Company by Pilko & Associates, Inc.

  • Phase II Investigation dated September 11, 1992 by Xxxxxxx-Xxxxxxx Environmental, covering Seller's neighboring property.

  • In all events, Seller or its representatives shall have the right, but not the obligation, to observe any and all activities associated with performance of any agreed Phase II Investigation, and may obtain half of any samples which the Assuming Bank or its representatives may collect during the Phase II Investigation.

  • In either case, the results of the Phase II Investigation shall be made available to both parties and the scope of the investigation and technical details shall be consented to by both Buyer and Seller, such consent not to be unreasonably withheld.

  • Buyer acknowledges receipt of Phase I Environmental Site Assessment dated April 19, 1996, and the UST Abandonment and Phase II Investigation Report dated June 25, 1996.

  • The Environmental Site ------------------------------------------ Assessment (if received within 40 days hereof) and, if applicable, the Phase II Investigation (if received within 60 days hereof), shall not contain any information that would reasonably be expected to result in a breach of any of the representations and warranties of the Sellers that are contained in Section 2.17 such that the conditions in Section 6.2(a) would not be satisfied on or prior to the Closing Date.

  • The Improvements do not contain any urea formaldehyde or asbestos except as disclosed in the Phase I Environmental Site Assessment dated October 10, 2006, and prepared by ECS LLP and that Limited Phase II Investigation dated November 15, 2006, and prepared by ECS-Texas, LLP.

  • The Environmental Site Assessment and the Phase II Investigation, if any, shall be completed within 40 days and within 60 days, respectively, of the date of this Agreement.

  • In all events, Seller or its representatives shall have the right, but not the obligation, to observe any and all activities associated with performance of any agreed Phase II Investigation, and may obtain half of any samples which Xxxxxx or his representatives may collect during the Phase II Investigation.

  • Even if the concentration is cleared in the course of the Phase II Investigation by the Cartel Court, such clearance may be appealed by the Austrian Competition Authorities.


More Definitions of Phase II Investigation

Phase II Investigation has the meaning set forth in Section 7.1.f. of this Agreement.
Sample 1
Phase II Investigation. Report Former Bury & Xxxxxxx Asphalt Plant" January 24, 1995, Xxxx & Associates, Inc. Xxxx & Associates, Inc. "Subsurface Investigation Report Former Bury & Xxxxxxx Asphalt Plant (MPCA Site ID# LEAK 00003598)" April 29, 1992, Xxxxx Intertec Environmental, Inc. "1991 Annual Report for Continued Groundwater Monitoring Former Bury & Xxxxxxx Asphalt Plant" April 29, 1992, Xxxxx Intertec Environmental, Inc. "A Report to City of Golden Valley 1990 Annual Report Former Bury & Xxxxxxx Asphalt Plant" May 23, 1991, Xxxxx Intertec Environmental, Inc. "Underground Storage Tank Excavation Former Bury & Xxxxxxx Asphalt Plant" August 30, 1990, Xxxxx Intertec Environmental, Inc. "EG-292 Site Study and Closure Plan Bury & Xxxxxxx Asphalt Plant Property Golden Valley, Minnesota" September 20, 1989, Xxxxx Environmental Laboratories, Inc. "EG-168 Environmental Evaluation Bury Xxxxxxx Site Golden Valley Minnesota" June 28, 1989, Xxxxx Environmental Laboratories, Inc. "Contaminated Soil Excavations Bury & Xxxxxxx Asphalt Plant" December 1, 1987, Xxxxx Environmental Laboratories, Inc.
Sample 1

Related to Phase II Investigation

  • Remedial investigation means a process to determine the nature and extent of a discharge of a contaminant at a site or a discharge of a contaminant that has migrated or is migrating from the site and the problems presented by a discharge, and may include data collected, site characterization, sampling, monitoring, and the gathering of any other sufficient and relevant information necessary to determine the necessity for remedial action and to support the evaluation of remedial actions if necessary;

  • clinical investigation means any systematic investigation in one or more human subjects, undertaken to assess the safety or performance of a device;

  • Background investigation means the investigation conducted by a licensee or applicant to support the determination of trustworthiness and reliability.

  • Complaint Investigation means an investigation of any complaint that has been made to a proper authority that is not covered by an abuse investigation.

  • Site investigation means the collection and evaluation of data adequate to determine whether or not discharged contaminants exist at a site or have migrated or are migrating from the site at levels in excess of the applicable remediation standards. A site investigation shall be developed based upon the information collected pursuant to the preliminary assessment;

  • Phase II means the second part of the tuition incentive assistance program which provides assistance in the third and fourth year of 4-year degree programs.

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase I Environmental Site Assessment means a Phase I environmental property assessment of the Assets that satisfies the basic assessment requirements set forth under the current ASTM International Standard Practice for Environmental Site Assessments (Designation E1527-13) or any other visual site assessment or review of records, reports or documents.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase I means the first part of the tuition incentive assistance program defined as the academic period of 80 semester or 120 term credits, or less, leading to an associate degree or certificate.

  • Phase I Environmental Assessment A “Phase I assessment” as described in, and meeting the criteria of, the ASTM, plus a radon and asbestos inspection.

  • Investigations The Xxxxxxx, when requested by one or a number of employees whom he/she represents, may investigate the basis for any dispute arising under this Agreement and may, at any stage, assist the employee(s) in seeking resolution of such dispute through the grievance procedure provided herein. A representative of the Union may substitute in place of the Xxxxxxx.

  • Investigational Product means the Study Drug identified above and the control material, as further detailed in the Protocol;

  • Initial Environmental Examination or “IEE” means the initial environmental examination for the Project, including any update thereto, prepared and submitted by the Borrower and cleared by ADB;

  • Investigation means the Bureau’s decision to hold and not process the Company’s license renewal applications identified in Appendix A due to the Company’s inability to certify compliance with its public file obligations.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase I Environmental Report means a report by an Independent Person who regularly conducts environmental site assessments in accordance with then current standards imposed by institutional commercial mortgage lenders and who has a reasonable amount of experience conducting such assessments.

  • EXPERIMENTAL OR INVESTIGATIONAL means any healthcare service that has progressed to limited human application, but has not been recognized as proven and effective in clinical medicine. See Experimental or Investigational Services in Section 3 for a more detailed description of the type of healthcare services we consider experimental or investigational.

  • Studies means activities needed to prepare project implementation, such as preparatory, mapping, feasibility, evaluation, testing and validation studies, including in the form of software, and any other technical support measure, including prior action to define and develop a project and decide on its financing, such as reconnaissance of the sites concerned and preparation of the financial package;

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Environmental Review means the Federal

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase III means Phase I (or Phase I/II), Phase II (or Phase II/III) and Phase III clinical trials, respectively, in each case as prescribed by applicable FDA IND Regulations, or any corresponding foreign statutes, rules or regulations.